DESCAMPS Diane : UMR_S1137 : Antiretroviral Resistance, Genetic Diversity and Therapeutic Strategies in HIV Infection

Unit : INSERM UMR_S1137 - IAME "Infection, Antimicrobials, Modelling, Evolution" - Universités Paris Diderot et Nord

UFR de Médecine Paris Diderot
INSERM UMR_S1137 IAME
Site Xavier Bichat
16 rue Henri Huchard
75018 PARIS

Speciality : Department IM

Director of the unit : Erick DENAMUR

Principal investigator :

DESCAMPS Diane
Email : diane.descampsSPAMFILTER@bch.aphp.fr Phone number: +33 (0)1 40 25 61 50

Composition of research team :

  • DESCAMPS Diane (PU-PH, HDR)
  • MATHERON Sophie (PU-PH, HDR)
  • YENI Patrick (PU-PH, HDR)
  • CHARPENTIER Charlotte (MCU-PH)
  • DAMOND FLorence (PH)
  • JOLY Véronique (PH)
  • LANDMAN Roland (PH)
  • LARROUY Lucielle (PH)
  • PEYTAVIN Gilles (PH)

5 Recent publications of the research team :

Yazdanpanah Y, Fagard C, Descamps D, Taburet AM, Colin C, Roquebert B, Katlama C, Pialoux G, Jacomet C, Piketty C, Bollens D, Molina JM, Chene G: High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trial, Clin Infect Dis 2009, 49:1441-1449

Charpentier C, Roquebert B, Colin C, Taburet AM, Fagard C, Katlama C, Molina JM, Jacomet C, Brun-Vezinet F, Chene G, Yazdanpanah Y, Descamps D: Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen, Aids 2010, 24:2651-2656

Benard A, van Sighem A, Taieb A, Valadas E, Ruelle J, Soriano V, Calmy A, Balotta C, Damond F, Brun-Vezinet F, Chene G, Matheron S: Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group, Clin Infect Dis 2011, 52:1257-1266

Larrouy L, Charpentier C,  Landman R , Capitant C, Chazallon C, Yeni P,  Peytavin G, Damond F, Brun-Vezinet F, Descamps D: Dynamics of gag-pol minority viral populations in naive HIV-1-infected patients failing protease inhibitor regimen, Aids 2011, 25:2143-2148

Visseaux B, Hurtado-Nedelec M, Charpentier C, Collin G, Storto A, Matheron S, Larrouy L, Damond F, Brun-Vezinet F, Descamps D : Molecular determinants of HIV-2 R5-X4 tropism in the V3 loop: development of a new genotypic tool, J Infect Dis 2012, 205:111-120.